The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Akram Pourshams
,
Sadaf G. Sepanlou
,
Kevin S Ikuta
,
Catherine Bisignano
,
Saeid Safiri
,
Gholamreza Roshandel
,
Mehdi Sharif
,
Morteza Khatibian
,
Christina Fitzmaurice
,
Molly R. Nixon
,
Nooshin Abbasi
,
Mohsen Afarideh
,
Elham Ahmadian
,
TOMI AKINYEMIJU
,
Fares Alahdab
,
Tahiya Alam
,
Vahid Alipour
,
Christine A. Allen
,
Nahla Hamed Anber
,
Alireza Ansari Moghaddam
,
Jalal Arabloo
,
Alaa Badawi
,
Mojtaba Bagherzadeh
,
Yaschilal Muche Belayneh
,
Belete Biadgo
,
Ali Bijani
,
Antonio Biondi
,
Tone Bjørge
,
Antonio M Borzì
,
Cristina Bosetti
,
Andrey Nikolaevich Briko
,
Nikolay Ivanovich Briko
,
Giulia Carreras
,
Felix Carvalho
,
Jee Young J Choi
,
Dinh-Toi Chu
,
Anh Kim Dang
,
Ahmad Daryani
,
Dragos Virgil Davitoiu
,
Gebre Teklemariam Demoz
,
Rupak Desai
,
Subhojit Dey
,
Hoa Thi Do
,
Huyen Phuc Do
,
Aziz Eftekhari
,
Alireza Esteghamati
,
Farshad Farzadfar
,
Eduarda Fernandes
,
Irina Filip
,
Florian Fischer
,
Masoud Foroutan
,
Mohamed M. Gad
,
Silvano Gallus
,
Birhanu Geta
,
Giuseppe Gorini
,
Nima Hafezi-Nejad
,
James D Harvey
,
Milad Hasankhani
,
Amir Hasanzadeh
,
Soheil Hassanipour
,
Simon I. Hay
,
Hagos D Hidru
,
Chi Linh Hoang
,
Sorin Hostiuc
,
Mowafa Househ
,
Olayinka Stephen Ilesanmi
,
Milena D Ilic
,
Seyed Sina Naghibi Irvani
,
Nader Jafari Balalami
,
Spencer L. James
,
Farahnaz Joukar
,
Amir Kasaeian
,
Tesfaye Dessale Kassa
,
Andre Pascal Kengne
,
Rovshan Khalilov
,
Ejaz Ahmad Khan
,
Amir Khater
,
Fatemeh Khosravi Shadmani
,
Jonathan M. Kocarnik
,
Hamidreza Komaki
,
Ai Koyanagi
,
Vivek Kumar
,
Carlo La Vecchia
,
Platon D Lopukhov
,
Farzad Manafi
,
Navid Manafi
,
Ana Laura Manda
,
Fariborz Mansour-Ghanaei
,
Dhruv Mehta
,
Varshil Mehta
,
Toni Meier
,
Hagazi Gebre Meles
,
Getnet Mengistu
,
Tomasz Miazgowski
,
Mehdi Mohamadnejad
,
Abdollah Mohammadian Hafshejani
,
Milad Mohammadoo Khorasani
,
Shafiu Mohammed
,
Farnam Mohebi
,
Ali H. Mokdad
,
Lorenzo Monasta
,
Maryam Moossavi
,
Rahmatollah Moradzadeh
,
Gurudatta Naik
,
Ionut Negoi
,
Cuong Tat Nguyen
,
Long Hoang Nguyen
,
Trang Huyen Nguyen
,
Andrew T Olagunju
,
Tinuke O Olagunju
,
Alyssa Pennini
,
Mohammad Rabiee
,
Navid Rabiee
,
Amir Radfar
,
Mahdi Rahimi
,
Goura Kishor Rath
,
David Laith Rawaf
,
Salman Rawaf
,
Robert C. Reiner
,
Nima Rezaei
,
Aziz Rezapour
,
Anas M. Saad
,
Seyedmohammad Saadatagah
,
Amirhossein Sahebkar
,
Hamideh Salimzadeh
,
Abdallah M Samy
,
Juan Sanabria
,
Arash Sarveazad
,
Monika Sawhney
,
Mario Šekerija
,
Pavel Shabalkin
,
Masood Ali Shaikh
,
RAJESH SHARMA
,
Sara Sheikhbahaei
,
Reza Shirkoohi
,
Sudeep K. Siddappa Malleshappa
,
Mekonnen Sisay
,
Kjetil Soreide
,
Sergey Soshnikov
,
Rasoul Sotoudehmanesh
,
Vladimir I Starodubov
,
Michelle L Subart
,
Rafael Tabarés-Seisdedos
,
Degena Bahray Bahrey Tadesse
,
Eugenio Traini
,
Bach Xuan Tran
,
Khanh Bao Tran
,
Irfan Ullah
,
Marco Vacante
,
Amir Vahedian-Azimi
,
Elena Varavikova
,
Ronny Westerman
,
Dawit Dawit Zewdu Wondafrash
,
Rixing Xu
,
Naohiro Yonemoto
,
Vesna Zadnik
,
Zhi-Jiang Zhang
,
Reza Malekzadeh
,
Mohsen Naghavi
Publication type: Journal Article
Publication date: 2019-12-01
scimago Q1
wos Q1
SJR: 11.398
CiteScore: 51.1
Impact factor: 38.6
ISSN: 24681253, 24681156
PubMed ID:
31648972
Gastroenterology
Hepatology
Abstract
Worldwide, both the incidence and death rates of pancreatic cancer are increasing. Evaluation of pancreatic cancer burden and its global, regional, and national patterns is crucial to policy making and better resource allocation for controlling pancreatic cancer risk factors, developing early detection methods, and providing faster and more effective treatments.Vital registration, vital registration sample, and cancer registry data were used to generate mortality, incidence, and disability-adjusted life-years (DALYs) estimates. We used the comparative risk assessment framework to estimate the proportion of deaths attributable to risk factors for pancreatic cancer: smoking, high fasting plasma glucose, and high body-mass index. All of the estimates were reported as counts and age-standardised rates per 100 000 person-years. 95% uncertainty intervals (UIs) were reported for all estimates.In 2017, there were 448 000 (95% UI 439 000-456 000) incident cases of pancreatic cancer globally, of which 232 000 (210 000-221 000; 51·9%) were in males. The age-standardised incidence rate was 5·0 (4·9-5·1) per 100 000 person-years in 1990 and increased to 5·7 (5·6-5·8) per 100 000 person-years in 2017. There was a 2·3 times increase in number of deaths for both sexes from 196 000 (193 000-200 000) in 1990 to 441 000 (433 000-449 000) in 2017. There was a 2·1 times increase in DALYs due to pancreatic cancer, increasing from 4·4 million (4·3-4·5) in 1990 to 9·1 million (8·9-9·3) in 2017. The age-standardised death rate of pancreatic cancer was highest in the high-income super-region across all years from 1990 to 2017. In 2017, the highest age-standardised death rates were observed in Greenland (17·4 [15·8-19·0] per 100 000 person-years) and Uruguay (12·1 [10·9-13·5] per 100 000 person-years). These countries also had the highest age-standardised death rates in 1990. Bangladesh (1·9 [1·5-2·3] per 100 000 person-years) had the lowest rate in 2017, and São Tomé and Príncipe (1·3 [1·1-1·5] per 100 000 person-years) had the lowest rate in 1990. The numbers of incident cases and deaths peaked at the ages of 65-69 years for males and at 75-79 years for females. Age-standardised pancreatic cancer deaths worldwide were primarily attributable to smoking (21·1% [18·8-23·7]), high fasting plasma glucose (8·9% [2·1-19·4]), and high body-mass index (6·2% [2·5-11·4]) in 2017.Globally, the number of deaths, incident cases, and DALYs caused by pancreatic cancer has more than doubled from 1990 to 2017. The increase in incidence of pancreatic cancer is likely to continue as the population ages. Prevention strategies should focus on modifiable risk factors. Development of screening programmes for early detection and more effective treatment strategies for pancreatic cancer are needed.Bill & Melinda Gates Foundation.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Cancers
26 publications, 5.22%
|
|
|
Frontiers in Oncology
13 publications, 2.61%
|
|
|
BMC Cancer
11 publications, 2.21%
|
|
|
Gastroenterology
9 publications, 1.81%
|
|
|
World Journal of Gastroenterology
8 publications, 1.61%
|
|
|
Pancreatology
8 publications, 1.61%
|
|
|
International Journal of Molecular Sciences
6 publications, 1.2%
|
|
|
Cureus
6 publications, 1.2%
|
|
|
Pancreas
5 publications, 1%
|
|
|
Therapeutic Advances in Medical Oncology
5 publications, 1%
|
|
|
Journal of Clinical Medicine
5 publications, 1%
|
|
|
Scientific Reports
5 publications, 1%
|
|
|
European Journal of Cancer
5 publications, 1%
|
|
|
PLoS ONE
5 publications, 1%
|
|
|
Heliyon
5 publications, 1%
|
|
|
Cancer Control
4 publications, 0.8%
|
|
|
Frontiers in Pharmacology
4 publications, 0.8%
|
|
|
European Journal of Cancer Prevention
4 publications, 0.8%
|
|
|
International Journal of Environmental Research and Public Health
4 publications, 0.8%
|
|
|
Journal of Gastrointestinal Cancer
4 publications, 0.8%
|
|
|
Journal of Hepato-Biliary-Pancreatic Sciences
4 publications, 0.8%
|
|
|
Cancer Medicine
4 publications, 0.8%
|
|
|
World Journal of Clinical Cases
3 publications, 0.6%
|
|
|
World Journal of Gastrointestinal Oncology
3 publications, 0.6%
|
|
|
Frontiers in Immunology
3 publications, 0.6%
|
|
|
British Journal of Cancer
3 publications, 0.6%
|
|
|
HPB
3 publications, 0.6%
|
|
|
Bailliere's Best Practice and Research in Clinical Gastroenterology
3 publications, 0.6%
|
|
|
Biochimica et Biophysica Acta - Reviews on Cancer
3 publications, 0.6%
|
|
|
5
10
15
20
25
30
|
Publishers
|
10
20
30
40
50
60
70
80
90
100
|
|
|
Elsevier
97 publications, 19.48%
|
|
|
Springer Nature
92 publications, 18.47%
|
|
|
MDPI
57 publications, 11.45%
|
|
|
Wiley
40 publications, 8.03%
|
|
|
Frontiers Media S.A.
35 publications, 7.03%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
20 publications, 4.02%
|
|
|
Baishideng Publishing Group
16 publications, 3.21%
|
|
|
Taylor & Francis
15 publications, 3.01%
|
|
|
SAGE
13 publications, 2.61%
|
|
|
Georg Thieme Verlag KG
8 publications, 1.61%
|
|
|
AME Publishing Company
8 publications, 1.61%
|
|
|
Spandidos Publications
7 publications, 1.41%
|
|
|
BMJ
7 publications, 1.41%
|
|
|
Cold Spring Harbor Laboratory
7 publications, 1.41%
|
|
|
American Association for Cancer Research (AACR)
5 publications, 1%
|
|
|
Oxford University Press
5 publications, 1%
|
|
|
Public Library of Science (PLoS)
5 publications, 1%
|
|
|
American Chemical Society (ACS)
4 publications, 0.8%
|
|
|
American Society of Clinical Oncology (ASCO)
4 publications, 0.8%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 0.6%
|
|
|
Massachusetts Medical Society
2 publications, 0.4%
|
|
|
Moffitt Cancer Center
2 publications, 0.4%
|
|
|
Society for Translational Oncology
2 publications, 0.4%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 0.4%
|
|
|
American Medical Association (AMA)
2 publications, 0.4%
|
|
|
Research Square Platform LLC
2 publications, 0.4%
|
|
|
Impact Journals
1 publication, 0.2%
|
|
|
PeerJ
1 publication, 0.2%
|
|
|
Society of Nuclear Medicine
1 publication, 0.2%
|
|
|
10
20
30
40
50
60
70
80
90
100
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
499
Total citations:
499
Citations from 2024:
182
(36.55%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Pourshams A. et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet Gastroenterology and Hepatology. 2019. Vol. 4. No. 12. pp. 934-947.
GOST all authors (up to 50)
Copy
Pourshams A. et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // The Lancet Gastroenterology and Hepatology. 2019. Vol. 4. No. 12. pp. 934-947.
Cite this
RIS
Cite this
BibTex (up to 50 authors)
Copy
@article{2019_Pourshams,
author = {Akram Pourshams and Sadaf G. Sepanlou and Kevin S Ikuta and Catherine Bisignano and Saeid Safiri and Gholamreza Roshandel and Mehdi Sharif and Morteza Khatibian and Christina Fitzmaurice and Molly R. Nixon and Nooshin Abbasi and Mohsen Afarideh and Elham Ahmadian and TOMI AKINYEMIJU and Fares Alahdab and Tahiya Alam and Vahid Alipour and Christine A. Allen and Nahla Hamed Anber and Alireza Ansari Moghaddam and Jalal Arabloo and Alaa Badawi and Mojtaba Bagherzadeh and Yaschilal Muche Belayneh and Belete Biadgo and Ali Bijani and Antonio Biondi and Tone Bjørge and Antonio M Borzì and Cristina Bosetti and Andrey Nikolaevich Briko and Nikolay Ivanovich Briko and Giulia Carreras and Felix Carvalho and Jee Young J Choi and Dinh-Toi Chu and Anh Kim Dang and Ahmad Daryani and Dragos Virgil Davitoiu and Gebre Teklemariam Demoz and Rupak Desai and Subhojit Dey and Hoa Thi Do and Huyen Phuc Do and Aziz Eftekhari and Alireza Esteghamati and Farshad Farzadfar and Eduarda Fernandes and Irina Filip and Florian Fischer and others},
title = {The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017},
journal = {The Lancet Gastroenterology and Hepatology},
year = {2019},
volume = {4},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/s2468-1253(19)30347-4},
number = {12},
pages = {934--947},
doi = {10.1016/s2468-1253(19)30347-4}
}
Cite this
MLA
Copy
Pourshams, Akram, et al. “The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.” The Lancet Gastroenterology and Hepatology, vol. 4, no. 12, Dec. 2019, pp. 934-947. https://doi.org/10.1016/s2468-1253(19)30347-4.
Profiles